TAM
BOLD

Tocqueville Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Tocqueville Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,700
Closed -$216K – 794
2019
Q3 		$216K Hold
7,700
– – ﹤0.01% 707
2019
Q2 		$292K Sell
7,700
-1,075
-12% -$41.3K ﹤0.01% 686
2019
Q1 		$342K Sell
8,775
-6,775
-44% -$194K ﹤0.01% 652
2018
Q4 		$332K Sell
15,550
-1,200
-7% -$31K 0.01% 613
2018
Q3 		$663K Hold
16,750
– – 0.01% 563
2018
Q2 		$640K Buy
16,750
+1,900
+13% +$70.4K 0.01% 570
2018
Q1 		$446K Buy
14,850
+500
+3% +$16.9K 0.01% 635
2017
Q4 		$448K Buy
+14,350
New +$394K 0.01% 636

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Tocqueville Asset Management's BOLD Position: Q4 2019 in Review

Tocqueville Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 7,700 shares — an estimated $216K sold.

Tocqueville Asset Management first reported a position in BOLD in Q4 2017 and held it in 8 quarters. The position peaked at $663K in Q3 2018. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • Tocqueville Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 7,700 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $216K.
  • Tocqueville Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2017 and held it in 8 quarters.
  • Tocqueville Asset Management's Audentes Therapeutics, Inc position peaked at $663K in Q3 2018.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Tocqueville Asset Management's 13F filing for Q4 2019, filed 14 Jan 2020.